RECRUITING

Confronting Cancer as a Community

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to better understand the cause of colorectal cancer and how to find the best treatment for Hispanic patients with colorectal cancer. The genetic information in the blood and tissues may explain why patients who have the same type of cancer and receive the same treatment do not always have the same results. By combining genetic (certain qualities or traits passed from parents to offspring) information with clinical data, such as the responses of different kinds of cancers to different treatments, this study could lead to more knowledge about why certain cancers occur and why they respond differently to treatments. Information gathered from this study may help researchers match treatments to the genetics of each patient and the genetic changes in their tumor. This approach is known as personalized medicine.

Official Title

Confronting Cancer as a Community

Quick Facts

Study Start:2022-05-25
Study Completion:2028-05-25
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06063928

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Self-reported Hispanic ethnicity
  2. * Diagnosed with colon or rectal cancer (at any time and stage; lifetime diagnosis and in survival are eligible)
  3. * Has a tumor tissue sample archived or plans to have tissue archived from a standard care procedure
  4. * Age \>= 18 years
  1. * Inability to understand and the willingness to sign a written informed consent

Contacts and Locations

Study Contact

Ashley Noriega
CONTACT
323-865-3000
Ashley.Noriega@med.usc.edu

Principal Investigator

Heinz-Josef Lenz, MD
PRINCIPAL_INVESTIGATOR
University of Southern California

Study Locations (Sites)

Los Angeles County-USC Medical Center
Los Angeles, California, 90033
United States
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033
United States

Collaborators and Investigators

Sponsor: University of Southern California

  • Heinz-Josef Lenz, MD, PRINCIPAL_INVESTIGATOR, University of Southern California

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-25
Study Completion Date2028-05-25

Study Record Updates

Study Start Date2022-05-25
Study Completion Date2028-05-25

Terms related to this study

Additional Relevant MeSH Terms

  • Colorectal Carcinoma